Guardant Health
GH
#1546
Rank
A$20.81 B
Marketcap
A$160.26
Share price
-2.36%
Change (1 day)
158.89%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.78. In 2024 the company made an earnings per share (EPS) of A-$5.30 an increase over its 2023 EPS that were of A-$6.38.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-5.42%
2024A-$5.30-16.82%
2023A-$6.38-33.13%
2022A-$9.5360%
2021A-$5.9655.04%
2020A-$3.84207.14%
2019A-$1.25-19.81%
2018A-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
A-$3.19-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A-$7.16 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA